Search by Drug Name or NDC
NDC 68436-0120-16 Sorbutuss 10; 100 mg/5mL; mg/5mL Details
Sorbutuss 10; 100 mg/5mL; mg/5mL
Sorbutuss is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Dextrum Laboratories Inc.. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 68436-0120-16Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 68436-0120-16Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 68436-0120 |
---|---|
Product ID | 68436-120_0d69a13b-41e2-22ae-e063-6294a90ad6b2 |
Associated GPIs | 43997003380920 |
GCN Sequence Number | 048653 |
GCN Sequence Number Description | guaifen/dextromethorphan/K Cit LIQUID 100-10-85 ORAL |
HIC3 | B3T |
HIC3 Description | NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION |
GCN | 14328 |
HICL Sequence Number | 022896 |
HICL Sequence Number Description | GUAIFENESIN/DEXTROMETHORPHAN HBR/POTASSIUM CITRATE |
Brand/Generic | Brand |
Proprietary Name | Sorbutuss |
Proprietary Name Suffix | NR |
Non-Proprietary Name | Sorbutuss |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | ORAL |
Active Ingredient Strength | 10; 100 |
Active Ingredient Units | mg/5mL; mg/5mL |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Labeler Name | Dextrum Laboratories Inc. |
Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH DRUG |
Application Number | M012 |
Listing Certified Through | 2024-12-31 |
Package
NDC 68436-0120-16 (68436012016)
NDC Package Code | 68436-120-16 |
---|---|
Billing NDC | 68436012016 |
Package | 474 mL in 1 BOTTLE, PLASTIC (68436-120-16) |
Marketing Start Date | 2007-01-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |